Regarding cisplatin-induced AKI usually causes renal tubular cell death and renal inflammation [5,19], this study investigated the therapeutic effects on cisplatin-induced AKI by pharmacologically inhibiting GSK-3β activation. Here, GSK3B is linked to acute kidney injury.